* MEDNAX Inc MD.N reported quarterly adjusted earnings of
33
cents per share for the quarter ended in March. The mean
expectation of eleven analysts for the quarter was for earnings
of 27 cents per share.
* Revenue rose 7.9% to $482.23 million from a year ago;
analysts
expected $474.19 million.
* MEDNAX Inc's reported EPS for the quarter was a loss of 25
cents.
* The mean earnings estimate of analysts had risen by
about 1.2%
in the last three months.
* In the last 30 days there have been no negative revisions
of
earnings estimates
* MEDNAX Inc shares had fallen by 3.2% this quarter and
lost 16.5%
so far this year.
* The company reported a quarterly loss of $21.19 million.
* Wall Street's median 12-month price target for MEDNAX Inc
is
$26.50
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 7
"hold" and 3 "sell" or "strong sell."
This summary was machine generated April 28 at 07:13 p.m. All
figures in US dollars unless otherwise stated